Why some high-risk patients aren't getting drugs to combat COVID

Antiviral medications have remained underused. A group of researchers wanted to know why — and what could be done about it.

Related Keywords

Boston ,Massachusetts ,United States ,California ,Paul Monach ,Richard Dang ,Davey Smith ,Drug Administration ,California Department Of Public Health ,Veterans Affairs Boston Healthcare System ,Veterans Health ,Us Centers For Disease ,Veterans Affairs ,Veterans Health Administration ,Va Boston Cooperative Studies Program ,Emily Alpert Reyes ,Los Angeles Times ,Disease Control ,Cooperative Studies Program ,Mortality Weekly Report ,California Department ,Public Health ,